Literature DB >> 8965109

Morvan's fibrillary chorea: remission after plasmapheresis.

A Madrid1, A Gil-Peralta, E Gil-Néciga, J R González, S Jarrín.   

Abstract

We evaluated the effects of plasmapheresis in two patients with Morvan's fibrillary chorea, one of whom had sigmoid carcinoma, with oligoclonal bands in the cerebrospinal fluid, and modifications of the lipid-oxidative muscle pattern. The use of plasmapheresis in the treatment of Morvan's fibrillary chorea has not been reported previously and in our patients improved the symptoms markedly.

Entities:  

Mesh：

Year:  1996        PMID： 8965109     DOI： 10.1007/bf00868410

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  8 in total

1.  A SYNDROME OF CONTINUOUS MUSCLE-FIBRE ACTIVITY.

Authors:  H Isaacs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-11       Impact factor: 10.154

2.  The syndrome of continuous muscle fibre activity: light and electron microscopic studies in muscle and nerve biopsies.

Authors:  S Ono; S Munakata; K Nagao; N Shimizu; N Shimizu
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

3.  Neuromuscular, autonomic and central cholinergic hyperactivity associated with thymoma and acetylcholine receptor-binding antibody.

Authors:  M Halbach; V Hömberg; H J Freund
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

4.  Autoimmune aetiology for acquired neuromyotonia (Isaacs' syndrome)

Authors:  S Sinha; J Newsom-Davis; K Mills; N Byrne; B Lang; A Vincent
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

5.  Syndrome of continuous muscle fiber activity and plasmacytoma with IgM paraproteinemia.

Authors:  U Zifko; M Drlicek; E Machacek; K Jellinger; W Grisold
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

6.  Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review.

Authors:  J Newsom-Davis; K R Mills
Journal:  Brain       Date:  1993-04       Impact factor: 13.501

7.  Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.

Authors:  M Solimena; F Folli; S Denis-Donini; G C Comi; G Pozza; P De Camilli; A M Vicari
Journal:  N Engl J Med       Date:  1988-04-21       Impact factor: 91.245

Review 8.  [What is left of Morvan's fibrillary chorea?].

Authors:  G Serratrice; J P Azulay
Journal:  Rev Neurol (Paris)       Date:  1994       Impact factor: 2.607
  8 in total
  7 in total

1.  Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome.

Authors:  Carlo Rinaldi; Cinzia Valeria Russo; Alessandro Filla; Giuseppe De Michele; Enrico Marano
Journal:  Neurol Sci       Date:  2009-03-04       Impact factor: 3.307

2.  Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma.

Authors:  E K Lee; R A Maselli; W G Ellis; M A Agius
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

3.  CASPR2-Related Morvan Syndrome: Autonomic, Polysomnographic, and Neuropsychological Observations.

Authors:  Panda Sudha Swayang; Atchayaram Nalini; Veeramani Preethish-Kumar; Kaviraja Udupa; Ravi Yadav; Seena Vengalil; Sheikh Sultana Reshma; Kiran Polavarapu; Saraswati Nashi; T N Sathyaprabha; Priya Treesa Thomas; Bhat Maya; Rajeshwaran Jamuna; Anita Mahadevan; M Netravathi
Journal:  Neurol Clin Pract       Date:  2021-06

4.  [Therapeutic apheresis for autoimmune encephalitis: a nationwide data collection].

Authors:  S Ehrlich; C M Fassbender; C Blaes; C Finke; A Günther; L Harms; F Hoffmann; K Jahner; R Klingel; A Kraft; T Lempert; M Tesch; J Thomsen; H Topka; J Jochim; C Veauthier; W Köhler
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

Review 5.  Autoimmune and paraneoplastic channelopathies.

Authors:  Steven Vernino
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

6.  Autoimmune channelopathies of the nervous system.

Authors:  Kleopas A Kleopa
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

Review 7.  Current Treatment Options for Peripheral Nerve Hyperexcitability Syndromes.

Authors:  Cheran Elangovan; Adeolu Morawo; Aiesha Ahmed
Journal:  Curr Treat Options Neurol       Date:  2018-05-28       Impact factor: 3.972
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.